Skip to content

M3VAS Validation in Polish Population

The Maudsley 3-item Visual Analogue Scale (M3VAS) Validation in Polish Population Diagnosed With Major Depressive Episode

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06412562
Enrollment
150
Registered
2024-05-14
Start date
2024-05-09
Completion date
2026-09-30
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Keywords

anhedonia; low mood; suicidality; depression; m3vas

Brief summary

Low mood and anhedonia represent the fundamental symptoms of major depressive disorder (MDD). Nevertheless, there is currently no standardized visual analogue scale available to assess the extent of both symptoms concurrently. The Maudsley 3-item Visual Analogue Scale (M3VAS) is a newly developed tool for participants to self-assess core symptoms of depression: mood quality, pleasure experience (anhedonia), and suicidality. Despite suicidality not being a primary symptom, it is included due to its critical relevance to safety. Participants will be instructed to rate the intensity and frequency of their experiences over the preceding two weeks by marking a 100 mm ungraded line. A researcher will then assign a numerical value based on the mark's position, utilizing the left edge as 0 and the right as 100. The total score range, combining the three symptoms, ranged from 0 (minimum) to 300 (maximum). The M3VAS exhibited good psychometric properties in British population. In this study, the objective is to assess the psychometric properties of the scale within the Polish population diagnosed with major depressive episode within major depressive disorder or bipolar disorder.

Interventions

DIAGNOSTIC_TESTThe Maudsley 3-item Visual Analogue Scale (M3VAS)

Patients will be asked to complete The Maudsley 3-item Visual Analogue Scale (M3VAS) and 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR-16).

Sponsors

King's College London
CollaboratorOTHER
Medical University of Gdansk
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Diagnosis as provided by DSM-5 criteria: Major depressive disorder (MDD) Bipolar disorder (BD)

Exclusion criteria

Diagnosis as provided by DSM-5 criteria: Psychotic disorders Current Mania or hypomania within bipolar disorder (BD)

Design outcomes

Primary

MeasureTime frameDescription
The Maudsley 3-item Visual Analogue Scale (M3VAS)BaselineTo analyze internal consistency and factor analysis

Secondary

MeasureTime frameDescription
16-item Quick Inventory of Depressive Symptomatology (QIDS-SR-16)BaselineTo analyze convergent validity with The Maudsley 3-item Visual Analogue Scale (M3VAS)

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026